X-Mozilla-Status: 0000
X-Mozilla-Status2: 00000000
X-Apparently-To: jeeproject@yahoo.com; Fri, 07 Apr 2017 18:09:43 +0000
Return-Path: <bounce-31110487_HTML-1027729945-52283992-10732224-416@bounce.mail.23andme.com>
Received-SPF: pass (domain of bounce.mail.23andme.com designates 136.147.187.132 as permitted sender)
X-YMailISG: BiaoACUWLDvAwHqHxU_ZGO.kOIU1IPHxjy3p.v0rbDgOq7bm
 OBpkP5tG_mSgsEqJwy0OSw3tshDINV28eiVETg9Eyvq_20hAn1EKOoyTz9dA
 MwsL8XQ9McXsDLMRy0qYA4IhbA8DBCU8ehM3fzGUY2Z0h537qYNeyxfxcVeh
 j3XbtMltH9d_DQRhX.FH6JiDw6vq2GOCPMzxGd4neJOiNVQF__QvLeQdfvH.
 .KduMgN_j1yferqXUXeRKgSsU7K_6uS8nObktktA93xW8TL0NiDa5iaK7hW_
 14pyZA.7sVKSvPN03eIGYRS2v7nLoVxXvWaSRSw84Qud37EB8_2Ildmb26PE
 y7YWQCNRQCHGbfpwrvunINsI7UHFD0.agZOBKaiyt5TPa9u8er3oSNTzPtZy
 xelffLYsI.iXXzs1u74Ht2jqDmfyiIinlcajcUbSFeCvYGU8qOvuyOEFUoZ1
 .ykV2L_yklXXpF6W4y4oNadfwHoUxPuGf77O2tD9WELLNBSje7__ZEhajwuR
 8pkSl586Uh2cEIMp5YkUQxHkF5xEvrctMMgnw.VcgMC4Hg4_fuOCMYDzVkEc
 XWcdd08wX9znLgK2Kr6ayyz97xgKbpWm41VjndZuuKcxcrwKnVOPmawACGhg
 jGJycYHwAk0xJuvU_chkfwQ1mGMppJ59M2MWclGyg0JHhk.tEg8cATSk8C5b
 gioiSinBnEOPPZGpzaBdVN6i5pBwNQNJq8YSvOfwDE2qkpfRX_RgwmuUHBab
 Vbm1LNboZfxEhEJ2q3B3R2kJIfamiFtZNu0oxecYnIFyAQ.nNa1EWeVgn_a0
 zeNCqits8I051OfckIHoZtSl85v8x4D3w3Es0LFRobBl.0l4O2NYpTf_t9g0
 HkKbbB7GDAPX8zQQ1Py7ZQWuF48_uj.i2pYY1iOyhqH80sNCz.cVZOPdVwcE
 GcVhPlEmbX8tk1OeVggM7sNZkDw3W4iJ2ShDI757yiqBFGf8RKtqAOR3TkL_
 l.jNMsG1VqvA0PFUrvwOX0svbKK20PQ7r3xMyj1zqiL3S3suVb28tFtsRvE.
 djFhNDhhaavRnMS1GO4utIYYnc9f1Mb3C515Z.wQoFAGfViMvgzHrJ9vPFrJ
 UMChMYUgXDLmzdcfH6V_po6GJnBBgNUvCghqCGv7HE7OsLTIDjyQhgBhuksu
 uGi0IX9_3wIoMvXVkshlZfBhNvSk4NUoxy8wwRkJGWSSY3szCE739fcWo7PE
 .K6MO0J_LMjUaF2vZI6g7BrddR2nO4ysLPxbfBcppzDRLckiO9ihh7hqo7vI
 csp5ivEDPw79QranbCW4aswwH8qGUBCurBxnh3C_cRIl49tsoFUXpHZs3V9r
 YtlnyWfRYjKLxnL9wYRh2OJJWWHWT4l8yk70C1GTSSpQpHdHHwE5L.moERI7
 MiEw8KmiqxVuy1izwf_oia5Nj_VNsEeWV6LdB2aE4EZcY6zNXiOMWcuLXeh1
 ulJZlXaH2aDOU57zj03d.2f9Nwt9tAnOPKDIBJqJLEw.83D5YLTLKMbCWYcp
 _mcM9Zij4pWNw7iO4IUWfwwhHfeGw4m1jYGlX60yEJgJoBpjhpQFrDmw10HJ
 5kbb_26hs8Rxvw3edY3rw83KmO3J.kYFOgqbXQ--
X-Originating-IP: [136.147.187.132]
Authentication-Results: mta1171.mail.ne1.yahoo.com  from=mail.23andme.com; domainkeys=pass (ok);  from=mail.23andme.com; dkim=pass (ok)
Received: from 127.0.0.1  (EHLO mta.mail.23andme.com) (136.147.187.132)
  by mta1171.mail.ne1.yahoo.com with SMTPS; Fri, 07 Apr 2017 18:09:43 +0000
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=200608; d=mail.23andme.com;
 h=From:To:Subject:Date:List-Unsubscribe:MIME-Version:List-ID:Message-ID:Content-Type; i=noreply@mail.23andme.com;
 bh=7sBWk9WE3kM20YCmnYHo1aWmPXI=;
 b=rLaLyi+FRCqraTCM4OUJsWVST/ivB0ucByzMvgo88lQ6joliCgVyzjhg8014DbEMPv9xMjCx3ApJ
   z9GF7RHai9iO1E2nQsf/61eOXIUV4UHCyxAiuNrju0Ik/nIa5BUAuNB2pOqR159maNfxwejE7G8d
   FuqoQr0yVk7DjxZAHrI=
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=200608; d=mail.23andme.com;
 b=xUfKO4lYC5ElC2GhM0m7FsFdvp6T/o1/3dc+trFAhOOI7S+juAVKekpvZiYHP2V8+rZAV9Bb5OPY
   gnUMOjZLYnEqu+cSJNv6/2Zr0VL2hpEaEQR9Dw7WfHFXtK9f/YHmlrL6M+BQTRgJBHN/X4Nj8gg/
   ozLctDTaP50fC4uaf5Y=;
Received: by mta.mail.23andme.com id hsvaue163hs1 for <jeeproject@yahoo.com>; Fri, 7 Apr 2017 18:06:29 +0000 (envelope-from <bounce-31110487_HTML-1027729945-52283992-10732224-416@bounce.mail.23andme.com>)
From: "23andMe" <noreply@mail.23andme.com>
To: <jeeproject@yahoo.com>
Subject: Good News About Health Reports
Date: Fri, 07 Apr 2017 12:06:29 -0600
List-Unsubscribe: <mailto:leave-fc521771746504797d131f2d205921-fdf115707763037f7c1d7470-fe571172776c07747c16-fe6a15707267067f7710-ff64107173@leave.mail.23andme.com>
MIME-Version: 1.0
List-ID: <10732224_52283992.xt.local>
X-CSA-Complaints: whitelistcomplaints@eco.de
x-job: 10732224_52283992
Message-ID: <57dd32d8-1505-4ce5-95c0-f53e7e2ed5af@ind1s01mta516.xt.local>
Content-Type: multipart/alternative;
	boundary="WdTIRIVPtOZM=_?:"
Content-Length: 10708

This is a multi-part message in MIME format.

--WdTIRIVPtOZM=_?:
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

23andMeHaving trouble viewing this email? 
https://view.mail.23andme.com/?qs=02bcf5a141cbcea12d938164df621ac010ad8ab52241b62b5c3c0a5ff2b1b3e0d79899d29960cbdcaa30018343e75b000f5b22ab5d11fb9ddc9d127d5f70613277614f45d3af15e38733a769b0909706 
View it in your browser .

 
https://click.mail.23andme.com/?qs=abb35930e5f658ca5a935b61a2b59e538164de7d90347c9794d5cfd936dc46335de02f3b40b81d530106dce4be396ab341e0bdcf49224bc7 
 

 
 
 
Dear Sam, 

I am happy to announce that the U.S. Food and Drug Administration (FDA) granted 23andMe authorization to market ten direct-to-consumer, genetic health risk reports.This new category of health reports will provide customers with information about genetic variants that could increase their risk for certain diseases. 
 

The authorization includes reports on Late-Onset Alzheimer's Disease, Parkinson's Disease, Celiac Disease and Hereditary Thrombophilia as well as six additional conditions. To learn more about these reports and the additional reports covered in the authorization, you can refer to the 
https://click.mail.23andme.com/?qs=abb35930e5f658ca705dfe32010dcd0e94cb457a9b6bc6a58eb976f74f1be4158f04b7b72e39b3730a6a3cf0ac1cb72a1cc9e8df25bb2962 
FDA's press release  or 
https://click.mail.23andme.com/?qs=abb35930e5f658cab608fd86c70fe0a0be1f074614c021edb17f614ce0893c2f5378b7b7de87bd1ab405ee9e85fca4c3b36766a372f05279 
our blog .
 

I am proud to say we are the first and only company to receive FDA authorization to market genetic health risk reports without a prescription.It's a defining moment - giving individuals direct access to more information about how their DNA could impact their health.
 

The first set of new genetic health risk reports to be released in the U.S. will include Late-Onset Alzheimer's Disease, Parkinson's Disease, Hereditary Thrombophilia, Alpha-1 Antitrypsin Deficiency, and a new carrier status report for Gaucher's Disease. These will be available by the end of April with additional reports to follow. Look for an email in the next few weeks about your eligibility to receive these reports. 


Anne Wojcicki
CEO and Co-Founder 

 

 
 
You are receiving this email because you are a customer of 23andMe. 




 
(c) 2017 23andMe, Inc. 899 W. Evelyn Avenue. Mountain View, CA 94041 

https://click.mail.23andme.com/?qs=abb35930e5f658cac84e6e90290f4e82a24aa306e6be395d155e212c795f7e8a77781d97419e039a859875e6ba6a60e68764b9f21c14d1ca 
update your 23andMe email preferences  | 
https://click.mail.23andme.com/unsub_center.aspx?qs=1890449f0bb25765a87d3bc05643520400c13b7b7c37e928df86b966efbf799e8f7b7abfa961e6676924310e488a4e520079e3d4a06ba77c55762f2d5fc9b8f3914d3cfca93f0b25 
unsubscribe from 23andMe news and updates emails
 
 





--WdTIRIVPtOZM=_?:
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>23andMe</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta name="viewport" content="width=device-width, initial-scale=1.0 " />
<meta name="format-detection" content="telephone=no" />
<style type="text/css">
body {
	margin: 0 !important;
	padding: 0 !important;
	-webkit-text-size-adjust: 100% !important;
	-ms-text-size-adjust: 100% !important;
	-webkit-font-smoothing: antialiased !important;
}
img {
	border: 0 !important;
	outline: none !important;
}
p {
	margin: 0px !important;
	padding: 0px !important;
}
table {
	border-collapse: collapse;
	mso-table-lspace: 0px;
	mso-table-rspace: 0px;
}
td, a, span {
	border-collapse: collapse;
	mso-line-height-rule: exactly;
}
.ExternalClass * {
	line-height: 100%;
}
</style>
</head>

<body>
<table width="100%" border="0" cellspacing="0" cellpadding="0" style="background-color:#d4d6d6;">

    <tr>
      <td align="center"><table width="560" border="0" align="center" cellpadding="0" cellspacing="0" >
                            <!-- pre header-->
                      <tr>
                        <td height="50" align="center" bgcolor="#d4d6d6" class="em_grey" style="font-family:'Helvetica', Arial, sans-serif; font-size:14px; line-height:17px; color:#929292; font-style:normal;">Having trouble viewing this email? <a href="https://view.mail.23andme.com/?qs=02bcf5a141cbcea12d938164df621ac010ad8ab52241b62b5c3c0a5ff2b1b3e0d79899d29960cbdcaa30018343e75b000f5b22ab5d11fb9ddc9d127d5f70613277614f45d3af15e38733a769b0909706" target="_blank" style="text-decoration:underline; color:#929292;">View it in your browser</a>.</td>
                      </tr>
                      <!--// pre header--> 
          <tr>
            <td align="right" style="background-color:#ffffff;"><img src="http://image.exct.net/lib/fe6a15707267067f7710/m/1/lactose_intolerance_email_ean_blue.jpg" width="287" height="57" alt="" style="display:block;" border="0" /></td>
          </tr>
          <tr>
            <td style="background-color:#ffffff;"><table width="100%" border="0" cellspacing="0" cellpadding="0">
              <tbody>
                <tr>
                  <td width="50">&nbsp;</td>
                  <td align="left"><a href="https://click.mail.23andme.com/?qs=abb35930e5f658ca5a935b61a2b59e538164de7d90347c9794d5cfd936dc46335de02f3b40b81d530106dce4be396ab341e0bdcf49224bc7" target="_blank"><img src="http://image.exct.net/lib/fe6a15707267067f7710/m/1/batch1_introtoresearch_consented_2.jpg" width="123" height="82" alt="23andMe" style="display:block;" border="0" /></a></td>
                  <td width="50">&nbsp;</td>
                </tr>
              </tbody>
            </table></td>
          </tr>
          <tr>
            <td height="20" align="center" style="font-family:'Helvetica Neue', Helvetica, Arial, sans-serif; font-size:30px; line-height:24px; color:#333435; font-weight:regular; background-color:#ffffff;">&nbsp;</td>
          </tr>

          <tr>
            <td height="40" bgcolor="#ffffff">&nbsp;</td>
          </tr>
          <tr>
            <td align="center" valign="top" bgcolor="#ffffff">
            <table width="100%" border="0" cellspacing="0" cellpadding="0">
              <tbody>
                <tr>
                  <td width="50">&nbsp;</td>
                  <td align="left" valign="top" style="font-family:'Helvetica Neue', Helvetica, Arial, sans-serif; font-size:16px; line-height:24px; color:#333435; text-align:left;">  
Dear Sam, <br/ ><br />
I am happy to announce that the U.S. Food and Drug Administration (FDA) granted 23andMe authorization to market ten direct-to-consumer, genetic health risk reports.  This new category of health reports will provide customers with information about genetic variants that could increase their risk for certain diseases. 
 <br/ ><br />
The authorization includes reports on Late-Onset Alzheimer's Disease, Parkinson's Disease, Celiac Disease and Hereditary Thrombophilia as well as six additional conditions. To learn more about these reports and the additional reports covered in the authorization, you can refer to the <a href="https://click.mail.23andme.com/?qs=abb35930e5f658ca705dfe32010dcd0e94cb457a9b6bc6a58eb976f74f1be4158f04b7b72e39b3730a6a3cf0ac1cb72a1cc9e8df25bb2962">FDA's press release</a> or <a href="https://click.mail.23andme.com/?qs=abb35930e5f658cab608fd86c70fe0a0be1f074614c021edb17f614ce0893c2f5378b7b7de87bd1ab405ee9e85fca4c3b36766a372f05279">our blog</a>.
 <br/ ><br />
I am proud to say we are the first and only company to receive FDA authorization to market genetic health risk reports without a prescription.  It's a defining moment - giving individuals direct access to more information about how their DNA could impact their health.
 <br/ ><br />
The first set of new genetic health risk reports to be released in the U.S. will include Late-Onset Alzheimer's Disease, Parkinson's Disease, Hereditary Thrombophilia, Alpha-1 Antitrypsin Deficiency, and a new carrier status report for Gaucher's Disease. These will be available by the end of April with additional reports to follow. Look for an email in the next few weeks about your eligibility to receive these reports. 
  <br/ ><br />
Anne Wojcicki  <br/ >
CEO and Co-Founder 

                    </td>
                  <td width="50">&nbsp;</td>
                </tr>
              

              </tbody>
            </table></td>
          </tr>
          <tr>
            <td align="center" bgcolor="#FBFCFD" style="background-color:#Ffffff;">
            
            
            
           
         





      
      </td>
          </tr>


          <tr>
            <td height="60" style="background-color:#ffffff;">&nbsp;</td>
          </tr>
          
          <tr>
            <td height="30" bgcolor="#d4d6d6">&nbsp;</td>
          </tr>
          <tr>
            <td bgcolor="#d4d6d6" align="center" style="font-family:Arial, Helvetica, sans-serif; font-size:11px; mso-line-height-rule:exactly; text-align:center; line-height:18px; color:#333435;" class="dividerHeader">You are receiving this email because you are a customer of 23andMe. 

                  <br />
                  <br />
                 
                  &copy; 2017 23andMe, Inc. 899 W. Evelyn Avenue. Mountain View, CA 94041 <br /><br />
               


  <span class="em_gray1" style="color:#6b6b6b"><a class="em_gray1" href="https://click.mail.23andme.com/?qs=abb35930e5f658cac84e6e90290f4e82a24aa306e6be395d155e212c795f7e8a77781d97419e039a859875e6ba6a60e68764b9f21c14d1ca" target="_blank" style="text-decoration:none; color:#6b6b6b;">update your 23andMe email preferences</a><span class="em_hide"> | </span><a class="em_gray1" href="https://click.mail.23andme.com/unsub_center.aspx?qs=1890449f0bb25765a87d3bc05643520400c13b7b7c37e928df86b966efbf799e8f7b7abfa961e6676924310e488a4e520079e3d4a06ba77c55762f2d5fc9b8f3914d3cfca93f0b25" target="_blank" style="text-decoration:none; color:#6b6b6b;"><span class="em_br"></span>unsubscribe from 23andMe news and updates emails</a></span>


</td>
          </tr>
          <tr>
            <td height="50" bgcolor="#d4d6d6">&nbsp;</td>
          </tr>
          <tr>
            <td bgcolor="#d4d6d6">&nbsp;</td>
          </tr>
      
      </table></td>
    </tr>

</table>
<img src="https://click.mail.23andme.com/open.aspx?ffcb10-fe571172776c07747c16-fde31d797561007b7112797d-fe6a15707267067f7710-fe661771746504797d13-fdf115707763037f7c1d7470-ff64107173" width="1" height="1">
</body>
</html>


--WdTIRIVPtOZM=_?:--


